Scholars Central

Conference abstractPublished 2019

Inhibition of β -site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via specific structure-activity relationship with a strong BBB permeability

Authors: Gil Hong Park, Susoma Jannat, Anand Balupuri, Md Yousof Ali, Seong Su Hong, Chun Whan Choi, Yun-Hyeok Choi, Jin-Mo Ku, Woo Jung Kim, Jae Yoon Leem, Ju Eun Kim, Abinash Chandra Shrestha, Ha Neul Ham, Kee-Ho Lee, Dong Min Kim, Nam Sook Kang

Korea University, Korea Chungnam National University, Korea Gyeonggido Business & Science Accelerator, Korea Woosuk University, Korea Korea Institute of Radiological and Biomedical Sciences, Korea Jeonju University, Ko

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

We extracted 15 pterosin derivatives from Pteridium aquilinum inhibiting β-site amyloid precursor protein cleaving enzyme 1 (BACE1) and cholinesterases involved in the pathogenesis of Alzheimer’s disease (AD). (2R)-Pterosin B inhibited BACE1, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50 of 29.6, 16.2 and 48.1 μM, respectively. Ki values and binding energies (kcal/ mol) between pterosins and BACE1, AChE and BChE corresponded to the respective IC50 values. (2R)-Pterosin B was a noncompetitive inhibitor against human BACE1 and BChE and a mixedtype inhibitor against AChE, binding to the active sites of corresponding enzymes. Molecular docking simulation of mixed-type and noncompetitive inhibitors for BACE1, AChE and BChE revealed the novel binding site-directed inhibition of the enzymes by pterosins and structureactivity relationship. (2R)-Pterosin B exhibited a strong BBB permeability with the effective permeability (Pe) of 60.3 × 10-6 cm/s on PAMPA-BBB. (2R)-Pterosin B and (2R,3R)-pteroside C significantly decreased the secretion of Aβ peptides from neuroblastoma cells overexpressing human β-Amyloid Precursor Protein at 500 μM. Conclusively, our study suggested that a few pterosins are potential scaffolds for multi-target-directed ligands (MTDLs) for AD therapeutics.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalArchives of Clinical Pathology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Gil Hong Park”
  • BylineArticles whose byline prints “Susoma Jannat”
  • BylineArticles whose byline prints “Anand Balupuri”
  • BylineArticles whose byline prints “Md Yousof Ali”
  • BylineArticles whose byline prints “Seong Su Hong”
  • BylineArticles whose byline prints “Chun Whan Choi”
  • BylineArticles whose byline prints “Yun-Hyeok Choi”
  • BylineArticles whose byline prints “Jin-Mo Ku”